620 related articles for article (PubMed ID: 18364001)
1. Tumor-induced tolerance and immune suppression by myeloid derived suppressor cells.
Marigo I; Dolcetti L; Serafini P; Zanovello P; Bronte V
Immunol Rev; 2008 Apr; 222():162-79. PubMed ID: 18364001
[TBL] [Abstract][Full Text] [Related]
2. Mammary tumor heterogeneity in the expansion of myeloid-derived suppressor cells.
Donkor MK; Lahue E; Hoke TA; Shafer LR; Coskun U; Solheim JC; Gulen D; Bishay J; Talmadge JE
Int Immunopharmacol; 2009 Jul; 9(7-8):937-48. PubMed ID: 19362167
[TBL] [Abstract][Full Text] [Related]
3. Tumor immunity: a balancing act between T cell activation, macrophage activation and tumor-induced immune suppression.
Sinha P; Clements VK; Miller S; Ostrand-Rosenberg S
Cancer Immunol Immunother; 2005 Nov; 54(11):1137-42. PubMed ID: 15877228
[TBL] [Abstract][Full Text] [Related]
4. Immature myeloid cells and cancer-associated immune suppression.
Kusmartsev S; Gabrilovich DI
Cancer Immunol Immunother; 2002 Aug; 51(6):293-8. PubMed ID: 12111117
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-13-regulated M2 macrophages in combination with myeloid suppressor cells block immune surveillance against metastasis.
Sinha P; Clements VK; Ostrand-Rosenberg S
Cancer Res; 2005 Dec; 65(24):11743-51. PubMed ID: 16357187
[TBL] [Abstract][Full Text] [Related]
6. Myeloid-derived suppressor cells in inflammatory bowel disease: a new immunoregulatory pathway.
Haile LA; von Wasielewski R; Gamrekelashvili J; Krüger C; Bachmann O; Westendorf AM; Buer J; Liblau R; Manns MP; Korangy F; Greten TF
Gastroenterology; 2008 Sep; 135(3):871-81, 881.e1-5. PubMed ID: 18674538
[TBL] [Abstract][Full Text] [Related]
7. Myeloid derived suppressor cells and their role in tolerance induction in cancer.
Fujimura T; Mahnke K; Enk AH
J Dermatol Sci; 2010 Jul; 59(1):1-6. PubMed ID: 20570112
[TBL] [Abstract][Full Text] [Related]
8. IL4Ralpha+ myeloid-derived suppressor cell expansion in cancer patients.
Mandruzzato S; Solito S; Falisi E; Francescato S; Chiarion-Sileni V; Mocellin S; Zanon A; Rossi CR; Nitti D; Bronte V; Zanovello P
J Immunol; 2009 May; 182(10):6562-8. PubMed ID: 19414811
[TBL] [Abstract][Full Text] [Related]
9. Skewing the Th cell phenotype toward Th1 alters the maturation of tumor-infiltrating mononuclear phagocytes.
Nonaka K; Saio M; Suwa T; Frey AB; Umemura N; Imai H; Ouyang GF; Osada S; Balazs M; Adany R; Kawaguchi Y; Yoshida K; Takami T
J Leukoc Biol; 2008 Sep; 84(3):679-88. PubMed ID: 18566103
[TBL] [Abstract][Full Text] [Related]
10. Antigen specificity of immune suppression by myeloid-derived suppressor cells.
Solito S; Bronte V; Mandruzzato S
J Leukoc Biol; 2011 Jul; 90(1):31-6. PubMed ID: 21486906
[TBL] [Abstract][Full Text] [Related]
11. Tumor escape mechanism governed by myeloid-derived suppressor cells.
Nagaraj S; Gabrilovich DI
Cancer Res; 2008 Apr; 68(8):2561-3. PubMed ID: 18413722
[TBL] [Abstract][Full Text] [Related]
12. Myeloid-derived suppressor cell role in tumor-related inflammation.
Dolcetti L; Marigo I; Mantelli B; Peranzoni E; Zanovello P; Bronte V
Cancer Lett; 2008 Aug; 267(2):216-25. PubMed ID: 18433992
[TBL] [Abstract][Full Text] [Related]
13. Myeloid-derived suppressor cells in mammary tumor progression in FVB Neu transgenic mice.
Abe F; Dafferner AJ; Donkor M; Westphal SN; Scholar EM; Solheim JC; Singh RK; Hoke TA; Talmadge JE
Cancer Immunol Immunother; 2010 Jan; 59(1):47-62. PubMed ID: 19449184
[TBL] [Abstract][Full Text] [Related]
14. Derangement of immune responses by myeloid suppressor cells.
Serafini P; De Santo C; Marigo I; Cingarlini S; Dolcetti L; Gallina G; Zanovello P; Bronte V
Cancer Immunol Immunother; 2004 Feb; 53(2):64-72. PubMed ID: 14593498
[TBL] [Abstract][Full Text] [Related]
15. Improving antitumor immune responses by circumventing immunoregulatory cells and mechanisms.
Lizée G; Radvanyi LG; Overwijk WW; Hwu P
Clin Cancer Res; 2006 Aug; 12(16):4794-803. PubMed ID: 16914564
[TBL] [Abstract][Full Text] [Related]
16. Contribution of myeloid-derived suppressor cells to tumor-induced immune suppression, angiogenesis, invasion and metastasis.
Ye XZ; Yu SC; Bian XW
J Genet Genomics; 2010 Jul; 37(7):423-30. PubMed ID: 20659706
[TBL] [Abstract][Full Text] [Related]
17. Immunosuppressive myeloid-derived suppressor cells can be converted into immunogenic APCs with the help of activated NKT cells: an alternative cell-based antitumor vaccine.
Ko HJ; Lee JM; Kim YJ; Kim YS; Lee KA; Kang CY
J Immunol; 2009 Feb; 182(4):1818-28. PubMed ID: 19201833
[TBL] [Abstract][Full Text] [Related]
18. Myeloid-derived suppressor cells contribute to oral cancer progression in 4NQO-treated mice.
Chu M; Su YX; Wang L; Zhang TH; Liang YJ; Liang LZ; Liao GQ
Oral Dis; 2012 Jan; 18(1):67-73. PubMed ID: 21883708
[TBL] [Abstract][Full Text] [Related]
19. Pathways mediating the expansion and immunosuppressive activity of myeloid-derived suppressor cells and their relevance to cancer therapy.
Talmadge JE
Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5243-8. PubMed ID: 17875751
[TBL] [Abstract][Full Text] [Related]
20. Inflammatory cell infiltration of tumors: Jekyll or Hyde.
Talmadge JE; Donkor M; Scholar E
Cancer Metastasis Rev; 2007 Dec; 26(3-4):373-400. PubMed ID: 17717638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
